2023-08-21 16:00:10 ET
More on Horizon Therapeutics
- Horizon Therapeutics: Can Investors Profit From Amgen Deal Confusion?
- Improved Outlook For Horizon Therapeutics And Amgen
- H orizon Therapeutics, Activision among best bets for M&A deals to close
- 2023 shaping up to be biggest year for biopharma M&A since pandemic
- Amgen says FTC has ignored commitments it made to address Horizon deal concerns (update)
- Seeking Alpha’s Quant Rating on Horizon Therapeutics
- Earnings data for Horizon Therapeutics
- Dividend for Horizon Therapeutics
For further details see:
Horizon Therapeutics gains amid speculation on potential FTC settlement on Amgen